Despite significant advances in diagnosis and therapy over the past 20 years, cancer remains one of the leading causes of death. Patients treated by conventional strategies commonly suffer from frequent relapses and metastases and experience severe side effects shortly after treatment. For example, doxorubicin hydrochloride (DOX), one of the most well-known cytostatic chemotherapeutic agents used in the treatment of a wide variety of cancers is often associated with severe suppression of hematopoiesis, and gastrointestinal and cardiac toxicity when it is administered in vivo directly. [1, 2] In order to enhance the therapeutic outcomes and reduce side effects of anticancer drugs, different types of drug carriers, including liposomes, [3] polymeric micelles, [4] [5] [6] polymersomes, [7, 8] carbon nanotubes, [9, 10] mesoporous silica nanoparticles, [11, 12] and polymeric nanoparticles [13] have been extensively studied to improve therapeutic outcomes. Hollow polymeric capsules that are engineered through the layer-bylayer (LbL) deposition of polymers onto a sacrificial template have also become of interest for drug delivery due to their controllable physicochemical and biological properties, including a broad suite of capsule materials, tunable size, selective permeability, and stimuli-responsive functionality for controlled release and degradation. [14] [15] [16] [17] Effective carriers should be able to encapsulate and release loaded therapeutic agents. To this end, capsules that respond to intracellular stimuli such as pH, temperature, redox potential, and enzymes to initiate cargo release are of particular interest. [18] pH-responsive drug delivery systems have been mostly exploited for triggered drug release at the tumor site and/or inside tumor cells, due to the pH gradient between tumor tissues (pH 5.7-6.8) and extracellular fluids (pH ~7.4) as well as the acidic environment inside endosomal (pH 5.5-6.0) and lysosomal (pH 4.5-5.0)
compartments. [19] [20] [21] Recently, we introduced one-step assembly of phenolic-based thin films as a rapid and simple alternative technology for template-mediated capsule preparation. [22] We reported that complexation between tannic acid (TA), a polyphenolic ligand, and metal ions, form robust nano-scaled films on various templates, affording hollow, metal-phenolic network (MPN)
capsules following template removal. [23, 24] Herein, we report the assembly of drug delivery systems that are engineered from these MPN coordination complex films and exhibit controllable pH-dependent degradability and intracellular drug delivery. The preparation of the drug-loaded capsules that incorporate the pH-responsive release mechanism is demonstrated in Scheme 1. As a proof-of-concept, poly(styrene sulfonate) (PSS)-doped calcium carbonate (CaCO 3 ) particles were easily prepared by co-precipitation in the presence of CaCl 2 and Na 2 CO 3 . [25] By simply mixing the PSS-doped CaCO 3 with DOX, large amounts of DOX could be deposited into the porous interior of the CaCO 3 templates. [26, 27] Electrostatic interaction, [28] hydrogen boding interaction, [29, 30] and hydrophobic interaction [31] stabilize the PSS-DOX complexes. Stable metal-polyphenol coordination films were then rapidly formed around the DOX-deposited (Table S1 ). By taking advantage of the diverse chelation ability of phenolic materials to form coordination complexes with different metal ions, the DOX-loaded MPN capsules can be functionalized by coordination with manganese (Mn) and gadolinium(Gd) for potential theranostic applications ( Figure   S2 ). [24] Due to the presence of the large excess of reactive phenolic hydroxyl groups on the capsule surface, the drug-loaded MPN capsules are also expected to undergo a variety of surface modifications through catechol-thiol reaction, [32, 33] metal coordination, [34] and boronic acid−catechol complexation [35] for more specific applications. The formation of coordination bonds between polyphenols and Al III is pH dependent. [34] Our previous study demonstrated that the capsule film formed from the coordination complex between Fe III and TA exhibits pH-dependent disassembly. [23, 24] However, the narrow pH range (3.0 -4.0) of disassembly has made it difficult to achieve controlled and selective release of therapeutic agents at relevant physiological conditions. Most recently, we observed significant differences in the disassembly kinetics of MPN capsules prepared from different metals in response to acidic conditions. [24] To examine whether the Al bonding interaction between DOX and PSS [30] and increased hydrophilicity of DOX [36] at lower pH. (Figure 3a, b) . The 3D-reconstructed fluorescence images further confirmed that the DOX-Al III -TA capsules were located within the WGA-stained cell membrane ( Figure S11 ).
Most importantly, DOX distributed in the nucleus and cytoplasm, suggesting efficient capsule internalization and intracellular DOX release. This also explains the degradation of TAAl III capsules mainly occurs in endosomal compartments, where the pH is low. As a result, the released DOX in the endosomes can readily diffuse into the cytoplasm through the endosomal membrane without endosomal disruption. [37, 38] These results prompted us to further explore whether the DOX-Al 
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